SEC Form 4 · accession 0001493152-15-000452
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Richard Wenkart
Director · 10% Owner
Period of report
Jan 13, 2015
Accepted (ET)
Feb 11, 2015 · 3:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible DebentureF2,F1 | $0.30 | Jan 13, 2015 | P | 2,166,666 | A | — | — | Common Stock | 2,166,666 | 2,166,666 | I |
Explanation of responses
- F1At any time after the original issue date until the Debenture is no longer outstanding, the Debenture shall be convertible, in whole or in part, into shares of Common Stock at the option of the reporting person. The conversion price is $0.30, subject to adjustment as provided in the Debenture. The maturity date of the Debenture is January 12, 2018.
- F2The reporting person is the owner and President of Derma Medical Systems Inc.